Evaluation of the BRAINDEX Brain Monitor in Cardiac Surgery, Interventional Comparative Study

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 9, 2024

Primary Completion Date

September 9, 2024

Study Completion Date

March 3, 2025

Conditions
Brain MonitorAnaesthesia
Interventions
DEVICE

Cerebral monitor

The study procedure consists of monitoring the values of 3 cerebral parameters: SctO2, bcSEF and ANI measured by the ARGOS sensor. These 3 parameters will be recorded and compared after the intervention with 3 parameters considered as standard: SctO2 measured by the INVOS 7100 cerebral oximeter, the bispectral index (BIS) measured by the BIS monitor and the ANI measured by the MDoloris monitor. These 3 reference parameters are once again usually monitored and recommended for all cardiac surgery.

Trial Locations (1)

69009

Clinique de la Sauvegarde, Lyon

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Clinique de la Sauvegarde

OTHER

lead

Braindex

INDUSTRY

NCT06594198 - Evaluation of the BRAINDEX Brain Monitor in Cardiac Surgery, Interventional Comparative Study | Biotech Hunter | Biotech Hunter